BioSpace News Archive

BioMidwest

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - June 24, 2022

Veru Inc., a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, announced the granting of inducement awards to three new employees.

June 24, 2022
·
10 min read
FDA

U.S. FDA Approves Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Breyanzi®.

June 24, 2022
·
23 min read
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D

Sanyou Biopharmaceuticals, a biological high-tech enterprise focusing on R&D and services of innovative antibody drugs, and Dragon Sail Pharmaceutical, a CDMO and CMO enterprise dedicated to providing world-leading high-end biological drug manufacture services, announced a long-term strategic partnership taking effective.

June 24, 2022
·
5 min read